CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,353 | -15.7% | 3,687 | +4.2% | 0.10% | -11.9% |
| Q2 2023 | $198,567 | +24.1% | 3,537 | 0.0% | 0.11% | +18.5% |
| Q1 2023 | $159,979 | +15.5% | 3,537 | +3.8% | 0.09% | +8.2% |
| Q4 2022 | $138,495 | -38.2% | 3,407 | -0.6% | 0.08% | -43.3% |
| Q3 2022 | $224,000 | +7.7% | 3,427 | 0.0% | 0.15% | +10.3% |
| Q2 2022 | $208,000 | -3.3% | 3,427 | 0.0% | 0.14% | +9.7% |
| Q1 2022 | $215,000 | +3.9% | 3,427 | +25.7% | 0.12% | +3.3% |
| Q4 2021 | $207,000 | -26.6% | 2,727 | +8.3% | 0.12% | -34.1% |
| Q3 2021 | $282,000 | +6.8% | 2,517 | +54.4% | 0.18% | -2.2% |
| Q2 2021 | $264,000 | +80.8% | 1,630 | +35.8% | 0.19% | +70.6% |
| Q1 2021 | $146,000 | – | 1,200 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
| Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
| NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
| ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
| Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
| Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
| Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
| Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
| Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
| Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |